Transaction DateRecipientSharesTypePriceValue
5th December 2020Arthur J Higgins73,529Exercise of derivative$0.00
1st December 2020Arthur J Higgins34,860Exercise of derivative$0.00
30th November 2020Louis J Jr Lavigne33,632Grant/award etc.$0.00
19th November 2020Louis J Jr Lavigne6,219Exercise of derivative$0.00
6th October 2020William Mckee5,263Open or private purchase$19.00$99,997.00
30th September 2020Arthur J Higgins143.85Grant/award etc.$0.00
30th September 2020Arthur J Higgins137.6Grant/award etc.$199.86$27,500.05
18th September 2020Daniel A. Peisert3,405Payment by withholding$0.70$2,383.50
18th September 2020Daniel A. Peisert11,623Exercise of derivative$0.00
19th August 2020Louis J Jr Lavigne6,218Exercise of derivative$0.00
Assertio Holdings
Assertio Holdings logo

Assertio Therapeutics, Inc. focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Ticker: ASRT
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1005201
Employees: 125
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $106 M (151%)
Inventory, Net: $518 Th (0%)
Assets, Current: $180 M (73%)
Property, Plant and Equipment, Net: $3 M (-7%)
Other Assets, Noncurrent: $4 M (-32%)
Assets: $219 M (-58%)
Accounts Payable, Current: $5 M (-69%)
Accrued Liabilities, Current: $25 M (0%)
Liabilities, Current: $122 M (-33%)
Other Liabilities, Noncurrent: $13 M (-3%)
Liabilities: $135 M (-71%)
Common Stock, Value, Issued: $8 Th (0%)
Retained Earnings (Accumulated Deficit): $359 M (-10%)
Stockholders' Equity (Parent): $84 M (0%)
Liabilities and Equity: $219 M (-58%)
Revenue: $21 M (0%)
Operating Income/Loss: $17 M (441%)
Other Income, net: $60 M (249%)
Provision for income taxes: $2 M (2%)
EPS (basic): $0.58 (0%)
EPS (diluted): $0.58 (0%)